Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study
2024 · Frontiers in Pharmacology · 7 citations
https://doi.org/10.3389/fphar.2024.1443045
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
55
Citations
4
h-index
2
i10-index
Xilai Ma is an academic researcher from First Automotive Works (China). The author has contributed to research in topics: Electromagnetic Compatibility and Noise Suppression & Electromagnetic Compatibility and Measurements & Topic Modeling. The author has an h-index of 4, co-authored 11 publications.
Click to start Chat